| The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties L Tattersall, KM Shah, DL Lath, A Singh, JM Down, E De Marchi, ... Journal of Bone Oncology 31, 100398, 2021 | 18 | 2021 |
| The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review VL Tippett, L Tattersall, NB Ab Latif, KM Shah, MA Lawson, A Gartland Oncogene, 1-19, 2022 | 5 | 2022 |
| YBX1-interacting small RNAs and RUNX2 can be blocked in primary bone cancer using CADD522 D Green, A Singh, VL Tippett, L Tattersall, KM Shah, C Siachisumo, ... Journal of Bone Oncology, 100474, 2023 | 3 | 2023 |
| Osteosarcoma L Tattersall, Z Davison, A Gartland Academic Press, 2020 | 3 | 2020 |
| A Systematic Review of the Expression, Signalling and Function of P2 Receptors in Primary Bone Cancer L Tattersall, DC Gagui, VL Tippett, NB Ab Latif, KM Shah, A Gartland Frontiers in Bioscience-Landmark 27 (4), 122, 2022 | 2 | 2022 |
| EU COST Action CA21130 PRESTO ĄP2X receptors as therapeutic targetsą inaugural meeting report L Tattersall, A Agrawal, E Adinolfi, A Gartland Purinergic Signalling, 1-13, 2023 | 1 | 2023 |
| P2RX7 inhibition reduces breast cancer induced osteolytic lesions-implications for bone metastasis KM Shah, L Tattersall, A Hussain, SC Macfarlane, A Williamson, ... bioRxiv, 2021.12. 31.474644, 2022 | | 2022 |
| Encyclopedia of Bone Biology L Tattersall, Z Davison, A Gartland Elsevier, 2020 | | 2020 |
| Purinergic signalling in osteosarcoma L Tattersall University of Sheffield, 2019 | | 2019 |
| P2X7R in primary bone cancer L Tattersall, E De Marchi, A Williamson, VF Di, MA Lawson, E Adinolfi, ... PURINERGIC SIGNALLING 14, S13-S14, 2018 | | 2018 |
